Introduced
by
To include Methylenedioxypyrovalerone (MDPV); 5,6-Methylenedioxy-2-aminoindane (MDAI); Naphyrone; Naphthylpyrovalerone; and Pyrovalerone as schedule 1 controlled substances, meaning they would be in the same illegal drug category as cocaine, methamphetamine, heroin, LSD, marijuana, etc. (with possession punishable by up to two years in prison, and dealers subject to seven years). Sometimes sold as “bath salts,” MPDV reportedly has effects similar to amphetamines.
Referred to the Committee on Judiciary
Reported without amendment
With the recommendation that the substitute (H-1) be adopted and that the bill then pass.
Substitute offered
To replace the previous version of the bill with one that revises details but does not change the substance as previously described.
The substitute passed by voice vote
Passed in the House 105 to 0 (details)
Referred to the Committee on Judiciary
Reported without amendment
With the recommendation that the bill pass.
Passed in the Senate 38 to 0 (details)
To include Methylenedioxypyrovalerone (MDPV); 5,6-Methylenedioxy-2-aminoindane (MDAI); Naphyrone; Naphthylpyrovalerone; and Pyrovalerone as schedule 1 controlled substances, meaning they would be in the same illegal drug category as cocaine, methamphetamine, heroin, LSD, marijuana, etc. (with possession punishable by up to two years in prison, and dealers subject to seven years). Sometimes sold as “bath salts,” MPDV reportedly has effects similar to amphetamines.
